Improving Transitions in CKD: Failure Mode

Slides:

Advertisements

Similar presentations

Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.

Advertisements

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Outcomes Associated With Microalbuminuria: Effect.

Copyright © 2015 by the American Osteopathic Association.

Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose,

Systemic Implementation Strategies to Improve Hypertension: The Kaiser Permanente Southern California Experience John J. Sim, MD, Joel Handler, MD, Steven.

Assessment and Diagnosis of Renal Dysfunction in the ICU

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD

Robert C. Stanton, MD American Journal of Kidney Diseases

Chronic Kidney Disease in Diabetes

Chronic Pain in End-Stage Renal Disease

Algorithm for guideline-directed medical therapy for patients with SIHD. Colors correspond to the class of recommendations in the ACCF/AHATable The.

Isolated Systolic Hypertension: An Update After SPRINT

Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician Joseph A. Vassalotti, MD, Robert Centor, MD,

Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional.

Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole

Sumeska Thavarajah, MD, Daphne H. Knicely, MD, Michael J. Choi, MD

Diagnosis and Management of Chronic Kidney Disease

Frederic Rahbari-Oskoui, MD, MS American Journal of Kidney Diseases

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Volume 79, Issue 9, Pages (May 2011)

Thinking Beyond New Clinical Guidelines: Update in Hypertension

Changing Terminology in Renal Research: The Impact of Consensus

Volume 93, Issue 4, Pages (April 2018)

Deborah J. Clegg, PhD, Michael Cody, MD, Biff F. Palmer, MD

A Decade After the KDOQI CKD Guidelines

Therapeutic Strategies for Heart Failure in Cardiorenal Syndromes

Membranous nephropathy: When and how to treat

Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus George L. Bakris, MD Mayo Clinic.

Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets David M. Spiegel, Kate Brady Kidney.

Management of Acute Kidney Injury: Core Curriculum 2018

Manish M. Sood, MD, Amy R. Sood, Robert Richardson, MD

Chronic Kidney Disease in Diabetes

Prehypertension and chronic kidney disease: the ox or the plow?

Impact of Electronic Acute Kidney Injury (AKI) Alerts With Automated Nephrologist Consultation on Detection and Severity of AKI: A Quality Improvement.

Chronic Pain in End-Stage Renal Disease

Nat. Rev. Cardiol. doi: /nrcardio

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Acute Kidney Injury and CKD: Chicken or Egg?

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta- analysis of Treatment Effects From 37 Randomized Trials Lesley A.

Set Theory: Nephrology ∩ Urology

Biff F. Palmer, MD American Journal of Kidney Diseases

Volume 84, Issue 1, Pages (July 2013)

Steven J. Rosansky, Richard J. Glassock Kidney International

CKD as an Underrecognized Threat to Patient Safety

Hypertension After Kidney Transplant

GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials Hiddo J. Lambers Heerspink, PhD, Hocine.

Dyslipidemia in children with chronic kidney disease

Polyunsaturated Fatty Acids and Kidney Disease

Treatment of Nephrotic Syndrome: Retrospection

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Resolved: The Case for CKD Clinics

Evidence and Outcomes in CKD

Within-Person Variability in Kidney Measures

Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W

The future of renoprotection: Frustration and promises

Volume 87, Issue 1, Pages (January 2015)

Current Concepts in Hemodialysis Vascular Access Infections

Isolated Systolic Hypertension: An Update After SPRINT

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter? Dimitris Mavridis, PhD American Journal.

Volume 73, Issue 5, Pages (March 2008)

Volume 80, Issue 10, Pages (November 2011)

KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

Juan Jesús Carrero, PhD American Journal of Kidney Diseases

Friends, social networks, and progressive chronic kidney disease

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

Percentage of patients found with a kidney function too low for recommended use of the drug using estimated glomerular filtration rate compared with creatinine.

Sumeska Thavarajah, MD, Daphne H. Knicely, MD, Michael J. Choi, MD

Presentation transcript:

Improving Transitions in CKD: Failure Mode Jerry Yee, MD Advances in Chronic Kidney Disease Volume 23, Issue 4, Pages 211-214 (July 2016) DOI: 10.1053/j.ackd.2016.05.001 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 CKD checklist. Abbreviations: ACC/AHA, American College of Cardiology/American Heart Association; ACEI, angiotensin-converting-enzyme inhibitor; ACR, albumin-to-creatinine ratio; AKI, acute kidney injury; ALK Phos, alkaline phosphatase; ARB, angiotensin type 1 receptor; ARF, acute renal failure; BP, blood pressure; CV, cardiovascular; CVD, cardiovascular disease; DR1, direct renin inhibitor; EAG, estimated average glucose; ESA, erythropoiesis-stimulating agent; GFR, glomerular filtration rate; HBV, hepatitis B virus; HGB, hemoglobin; iPTH, intact parathyroid hormone; LDL-C, low-density lipoprotein cholesterol; MRA, aldosterone receptor antagonist; MVI, multiple vitamin; NDHPCCB, non-dihydropyridine calcium channel blocker; NSAID, nonsteroidal anti-inflammatory drug; QIV, quadrivalent inactivated influenza vaccine; TSAT, transferrin saturation; UPC, urine protein-to-creatinine ratio; UTI, urinary tract infection. Adapted from Chronic Kidney Disease—a collaborative approach: clinical practice recommendations for primary care physicians & healthcare providers (monograph). Eds. G. Krol and J. Yee. Edition 7.0. Dynamic Marketing, LLC (Livonia). 2016; p. 73. Advances in Chronic Kidney Disease 2016 23, 211-214DOI: (10.1053/j.ackd.2016.05.001) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions